theophylline has been researched along with thromboplastin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Losonczy, H; Nagy, I; Szaksz, I | 1 |
Tait, JF; Thiagarajan, P | 1 |
Förster, KH; Müller, KH | 1 |
Deguchi, H; Gabazza, EC; Hayashi, N; Suzuki, K; Takeya, H; Urano, H; Wada, H | 1 |
Zhou, H | 1 |
5 other study(ies) available for theophylline and thromboplastin
Article | Year |
---|---|
[Effect of bencyclan and theophylline on changes of platelet aggregation and factor 3 activity].
Topics: Bencyclane; Cycloheptanes; Drug Synergism; Humans; Platelet Aggregation; Theophylline; Thromboplastin | 1979 |
Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles.
Topics: 4-Chloromercuribenzenesulfonate; Adenosine; Affinity Labels; Alkaloids; Anions; Annexin A5; Binding Sites; Blood Platelets; Bucladesine; Calcimycin; Calcium-Binding Proteins; Colforsin; Collagen; Cyclic GMP; Factor Va; Flow Cytometry; Humans; Nitroprusside; Phospholipids; Platelet Aggregation; Pregnancy Proteins; Signal Transduction; Staurosporine; Theophylline; Thromboplastin | 1991 |
[Treatment problems in acute circulation disorders of the inner ear using low molecular dextrans].
Topics: Acute Disease; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Deafness; Dextrans; Ear, Inner; Evaluation Studies as Topic; Female; Hearing Disorders; Humans; Ischemia; Labyrinth Diseases; Male; Nicotinic Acids; Prothrombin Time; Theophylline; Thrombelastography; Thromboplastin; Time Factors | 1972 |
Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes.
Topics: Adenosine; Dilazep; Endothelium, Vascular; Gene Expression; Humans; Monocytes; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Agonists; Tetradecanoylphorbol Acetate; Theophylline; Thrombin; Thromboplastin; Tumor Necrosis Factor-alpha | 1997 |
Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
Topics: Adrenergic Antagonists; Antiphospholipid Syndrome; Cell Separation; Dilazep; Dipyridamole; Gene Expression; Humans; Immunoglobulin G; Monocytes; Platelet Aggregation Inhibitors; RNA, Messenger; Theophylline; Thromboplastin | 2004 |